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ABSTRACT
Over the last decade, many catalytically active DNA
molecules (deoxyribozymes; DNA enzymes) have
been identified by in vitro selection from random-
sequenceDNApools.Thisarticlefocusesondeoxyri-
bozymes that cleave RNA substrates. The first DNA
enzyme was reported in 1994 and cleaves an RNA
linkage. Since that time, many other RNA-cleaving
deoxyribozymes have been identified. Most but not
all of these deoxyribozymes require a divalent metal
ion cofactor such as Mg
21 to catalyzeattack by aspe-
cific RNA 20-hydroxyl group on the adjacent phos-
phodiester linkage, forming a 20,30-cyclic phosphate
anda50-hydroxylgroup.Severaldeoxyribozymesthat
cleave RNA have utility for in vitro RNA biochemistry.
Some DNA enzymes have been applied in vivo to
degrade mRNAs, and others have been engineered
into sensors. The practical impact of RNA-cleaving
deoxyribozymes should continue to increase as
additional applications are developed.
INTRODUCTION
Deoxyribozymes are DNA molecules with catalytic activity.
Their RNA analogues, ribozymes, participate in fundamental
reactions of modern biochemistry such as viral RNA self-
processing (1), RNA splicing (2,3), and translation of RNA
into protein (4,5). Ribozymes are widely hypothesized to have
both carried information and performed catalysis during the
primordial ‘RNA World’ (6,7). Unlike ribozymes, deoxyri-
bozymes are not known to exist naturally. For either RNA
or DNA, our chemical understanding is insufﬁcient to allow
prediction of a speciﬁc nucleotide sequence that will catalyze
a desired reaction. Despite this lack of predictive ability (and,
for DNA, without any clues from nature), artiﬁcial ribozymes
and deoxyribozymes can readily be identiﬁed through in vitro
selection (8,9). In this approach, large random-sequence
‘pools’ of nucleic acids are iteratively examined until a
small number of catalytically active sequences are obtained
(10,11). These nucleic acid enzymes can be studied to deter-
mine their catalytic abilities, structures and mechanisms. In
some cases, they can also be used for practical applications.
The known natural ribozymes all function with nucleic acid
substrates, with the important exception of the ribosome that
creates peptide bonds (1). In contrast, artiﬁcial ribozymes
identiﬁed by in vitro selection catalyze a growing variety of
chemical reactions (12–18). For deoxyribozymes, the sub-
strates have almost always been nucleic acids themselves
[with a few exceptions; (19,20)], and a number of recent
reviews have addressed the scope of DNA’s catalytic activity
using such substrates (21–25). This article focuses speciﬁcally
on deoxyribozymes that cleave RNA. Deoxyribozymes have
also been termed DNA enzymes or catalytic DNA, and
these terms are used interchangeably here. The contraction
‘DNAzyme’ will generally be avoided.
The ﬁrst reported DNA enzyme was described by Breaker
and Joyce (26) in December 1994 and cleaves a speciﬁc RNA
linkage embedded within a longer nucleic acid strand. Many
RNA-cleaving deoxyribozymes have been identiﬁed in the
intervening decade (27–36). Some of these DNA enzymes
have excellent catalytic rates, turnover numbers and abilities
to cleave a wide range of RNA substrate sequences, and their
practical utility has been exploited in several ways. The fol-
lowing sections describe how RNA-cleaving deoxyribozymes
have been identiﬁed, characterized and applied in biochem-
istry and other areas.
IN VITRO SELECTION OF DEOXYRIBOZYMES
THAT CLEAVE RNA, PART 1: THE FIRST
EXPERIMENTS
All known RNA-cleaving deoxyribozymes catalyze the
chemically identical cleavage reaction: attack of an RNA
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doi:10.1093/nar/gki93020-hydroxyl group on the adjacent phosphodiester linkage,
which forms 20,30-cyclic phosphate and 50-hydroxyl RNA
termini (Figure 1). This intramolecular cleavage reaction is
also catalyzed by many protein ribonucleases such as RNase
A, and the cleavage mechanism has been widely studied both
in proteins and in small model systems (37). Formation of an
RNA 20,30-cyclic phosphate via intramolecular cleavage is
facile even without catalysis; e.g. simply incubating an
RNA strand under basic conditions leads to random scission
along the entire length of the strand (38,39). Therefore, DNA
does not have to work particularly hard to increase the rate
of an already-favorable reaction. Nevertheless, the extremely
high selectivity with which deoxyribozymes have been shown
to cleave RNA substrates at particular locations is intriguing
and useful.
In the earliest effort to identify catalytic DNA (26), ﬁve
iterated selection rounds were used to identify a Pb
2+-
dependent deoxyribozyme that cleaves RNA according to
the reaction of Figure 1. The selection strategy used a nucleic
acid substrate made entirely from DNA except with a single
embedded ribonucleotide linkage, which directed cleavage to
the sole RNA junction within the strand (Figure 2, strategy 1).
For brevity, the substrate is termed here ‘the RNA substrate’,
although only one linkage was in fact RNA; later experiments
used substrates that had a longer stretch of RNA nucleotides
Figure 1. RNA cleavage with formation of 20,30-cyclic phosphate and
50-hydroxyl termini. This reaction can occur alone or with a catalyst such as
a protein enzyme, ribozyme or deoxyribozyme. In most but not all cases,
a divalent metal ion cofactor (M
2+) is required to achieve an appreciable
reaction rate.
Figure 2. InvitroselectionstrategiesforidentifyingRNA-cleavingdeoxyribozymes.(A)Thegeneralfour-stepselectionstrategy,whichinvolvesiteratedroundsof
PCR to incorporate biotin; streptavidin chromatography to isolate the single-stranded nucleic acid; M
2+-catalyzed RNA cleavage; and PCR to regenerate the pool,
whichhasbeenenrichedindeoxyribozymescapableofcleavingRNA.(B)Simplifieddepictionsofthethreestrategyvariationsusedinallselectionexperimentsfor
RNA-cleavingDNAenzymesreportedtodate.Instrategy1,asingleribonucleotidelinkage(rA)isthecleavagetarget,andinteractionsbetweenthesubstratestrand
and the deoxyribozyme are not pre-programmed. This strategywas used for the first in vitro selection effort that identified catalytic DNA,which resultedin a Pb
2+-
dependent RNA-cleaving deoxyribozyme (26), and it has been employed in other studies as well (28,33). In strategy 2, the single ribonucleotide cleavage site was
placedbetweentwoWatson–Crickbindingarms,asfirstreportedbyBreakerandJoyce(27)andusedinseveralsubsequentexperiments(30,32,33,36,40).Instrategy
3,a12ntstretchofRNAratherthanasingleribonucleotidelinkagewasthecleavagetarget,givingrisetothe10–23and8–17deoxyribozymes(29).Thebiotinylated
RNA–DNA chimera was generated during the first step of each selection round by primer extension using reverse transcriptase instead of PCR (not depicted
explicitly).
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process was 50-biotinylated, successful RNA cleavage also
separated the biotin tag from the 50 nt (N50) DNA random
region. This allowed the isolation of catalytically active
DNA sequences by streptavidin chromatography, because
the functional DNA sequences lost their biotin tag and were
not retained on the column. As in essentially all selection
efforts, the ‘winning’ deoxyribozyme sequences that survived
a particular selection round were used to initiate another
round of selection, and the entire process was iterated multiple
times.
At the end of the selection procedure,whensufﬁciently high
RNA cleavage activity was present in the pool as a whole,
individual deoxyribozyme sequences were identiﬁed by stan-
dard cloning procedures. The new Pb
2+-dependent deoxyri-
bozyme was found to interact with the RNA substrate using
Watson–Crick binding arms on either side of the initially
random enzyme region (sometimes called the catalytic
core), as shown in Figure 3A. This modular arrangement spa-
tially separates binding and catalytic functions and has sub-
sequently been found for many of the deoxyribozymes that
cleave RNA, as described below. As originally obtained, the
Figure 3. GalleryofRNA-cleavingdeoxyribozymesidentifiedbyinvitroselection.Mostofthesedeoxyribozymesfunctionintheintermolecularformatforintrans
cleavage of an RNA linkage. Thick lines and lowercase letters denote RNA; thin lines and uppercase letters denote DNA, and the green arrow marks the cleavage
site. The DNA enzyme regions are green; DNA nucleotides involved in Watson–Crick base pairing are brown; nucleotides of the substrate to the 50-side of the
cleavagesitearered;andnucleotidestothe30-sideareblue.Forclarity,notallnucleotidesareshownexplicitly,butthisdoesnotnecessarilyimplyalackofsequence
requirements. In panel D, the 8–17 deoxyribozyme is shown with the RNA cleavage site requirement a#g. However, the closely related 17E deoxyribozyme (32)
cancleaven#g(althougha#gandg#garepreferred).Furthermore,acomprehensivestudyshowedthat8–17variantscanbeidentifiedthatcollectivelycleavealmost
any RNA dinucleotide linkage (36). In panel H, the letters F and Q denote a fluorophore and quencher that are separated upon cleavage by the signaling
deoxyribozyme.
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2+-dependent deoxyribozyme cleaves near its own 50-termi-
nus (cleavage in cis). Because of the simple Watson–Crick
nature of the deoxyribozyme-substrate interactions, engineer-
ing the Pb
2+-dependent DNA enzyme to work intermolecu-
larly (in trans) was achieved in straightforward fashion by
removing the covalent loop that connects the RNA substrate
with the DNA.
When the substrate for the Pb
2+-dependent deoxyribozyme
was replaced with an all-RNA analogue (i.e. not just a single
RNA linkage at the cleavage site), catalytic activity was nearly
abolished. This suggested that identiﬁcation of deoxyri-
bozymes for cleavage of all-RNA substrates—which would
be of greater practical value—may require use of all-RNA
substrates during the selection procedure itself. The Pb
2+-
dependent deoxyribozyme cleaved the lone RNA linkage
in trans with kcat ¼ 1 min
 1 and Km ¼ 2 mMa t1m M
Pb
2+ (pH 7.0) and 23 C (with 0.5 M each NaCl and
KCl present as well). From these values, kcat/Km ¼
5 · 10
5 M
 1 min
 1, and multiple-turnover was clearly
evident; e.g. 46 turnovers were observed in 90 min. The uncat-
alyzed rate of RNA cleavage under the same conditions (i.e.,
spontaneous RNA cleavage in the absence of the deoxyri-
bozyme) was kuncat ¼ 10
 5 min
 1, leading to a calculated
rate enhancement kcat/kuncat of 10
5. This value is near that
of the hammerhead ribozyme (41). Therefore, despite earlier
speculation to the contrary (42), even this initial experimental
study suggested that deoxyribozymes have no inherent func-
tional limitations relative to their ribozyme cousins, despite
the absence of 20-hydroxyl groups in DNA.
Breaker and Joyce (27) immediately followed up their
ﬁrst study by identifying a Mg
2+-dependent RNA-cleaving
deoxyribozyme. In this second effort, an N40 DNA region
was explicitly positioned between two binding arm regions
that interacted with their nucleic acid substrate by Watson–
Crick base pairs (Figure 2, strategy 2). As in the ﬁrst effort, a
cleavage substrate with only a single ribonucleotide linkage
was used.After six rounds of selection,aninitial DNA enzyme
clone had kobs ¼ 0.002 min
 1 under single-turnover condi-
tions at 1 mM Mg
2+ (pH 7.0) and 23 C. Re-selection was
performed by partially randomizing the enzyme region to
the extent of 15% at each nucleotide and performing seven
additional selection rounds (therebytechnicallymakingthisan
‘evolution’ experiment, because evolution is selection coupled
withintroduction of variation after the start of the experiment).
The overall effort led to the E2 deoxyribozyme (Figure 3B),
which has kobs ¼ 0.01 min
 1 at 1 mM Mg
2+ and kobs ¼
0.08 min
 1 under saturating Mg
2+ of >100 mM. As observed
for the Pb
2+-dependent deoxyribozyme, the rate enhancement
kobs/kuncat of E2 was about 10
5, and an all-RNA substrate was
not cleaved.
A third selection effort for RNA-cleaving deoxyribozymes
was undertaken by Faulhammer and Famulok (28). These
investigators originally sought a histidine-dependent deoxyri-
bozyme and thus included only a small amount of Mg
2+
(0.5 mM) in their experiments, which were performed using
a selection strategy similar to that used in the initial Pb
2+ effort
(strategy 1 of Figure 2). Here, an N74 region and 10 selection
rounds were used, again with a single ribonucleotide linkage
as the cleavage site. Surprisingly, the resulting Mg5 deoxyri-
bozyme was histidine-independent and preferred Ca
2+ over
Mg
2+ as the metal ion cofactor, although Ca
2+ was never
present during the selection protocol. Indeed, Ca
2+ was
favored by an order of magnitude in rate over Mg
2+,w i t h
kcat for Ca
2+ of 0.1 min
 1 and Km ¼ 6 mMa t1 0m MC a
2+
(pH 7.0) and 37 C( kcat/Km ¼ 1.6 · 10
4 M
 1 min
 1). The rate
enhancement kcat/kuncat for Ca
2+ was  10
4 (43).
IN VITRO SELECTION OF DEOXYRIBOZYMES
THAT CLEAVE RNA, PART 2: THE SECOND
GENERATION OF EXPERIMENTS
Because all three of the initially identiﬁed deoxyribozymes
could not cleave an all-RNA substrate, which was never
available to the DNA during the selection procedure itself,
it seemed opportune to perform a selection experiment in
which the substrate had a long stretch of ribonucleotides as
the cleavage target. In addition, although the rate enhance-
ments over the uncatalyzed background cleavage rate were
high in the initial investigations, catalytic parameters such
as kcat/Km were suboptimal. Santoro and Joyce (29) addressed
both of these issues in a landmark study that provided what
has become the two most commonly used RNA-cleaving
deoxyribozymes. Their experiment used a modiﬁed selec-
tion approach in which an all-RNA substrate strand was
presented to an N50 DNA pool, which could cleave
anywhere along the 12 nt length of the RNA sequence
(Figure 2, strategy 3).
After 8–10 rounds of selection, cleavage was observed at
two favored sites within the 12 nt RNA region. The 8–17 and
10–23 deoxyribozymes (each of which were named for the
round and clone number by which they were identiﬁed) were
chosen for further study because they interacted with the RNA
substrate using simple Watson–Crick binding arms, which
would facilitate practical applications. Re-selections starting
with the initially cloned sequences were used to provide
information on the optimal catalytic cores (Figure 3C and D).
For 10–23, kcat ¼ 0.15 min
 1 and Km ¼ 0.5 nM under simu-
lated physiological conditions of 2 mM Mg
2+, 150 mM NaCl
(pH 7.5), and 37 C( kcat/Km ¼ 3 · 10
8 M
 1 min
 1). Because
the apparent Km for Mg
2+ under these conditions was much
higher ( 180 mM), kcat at 2 mM Mg
2+ was clearly not maxi-
mal. Under more typical in vitro conditions of 50 mM Mg
2+
(pH 8.0) and 37 C, kcat ¼ 3 min
 1 and Km ¼ 0.8 nM
(kcat/Km ¼ 4 · 10
9 M
 1 min
 1). This value of kcat/Km is
1–2 orders of magnitude higher than for the naturally
occurring hammerhead or hairpin RNA-cleaving ribozymes,
further demonstrating that DNA has no inherent catalytic
inferiority relative to RNA. As noted by the authors,
10–23’s value of kcat is much less favorable (by 10
4-fold)
than kcat for a protein ribonuclease such as RNase A, but
10–23’s value of Km is much more favorable (by 10
5-fold).
Thus, by the kcat/Km criterion, deoxyribozymes are at least as
good as—if not better than—protein enzymes at cleaving
RNA. However, it is clear that a very favorable Km for
10–23 and related deoxyribozymes can be obtained simply
by increasing the binding arm lengths. This is because
more Watson–Crick base pairs lead to tighter binding, and
of course such a strategy is not available to a protein enzyme.
It is important to note that the favorable deoxyribozyme Km
is eventually achieved at the expense of multiple turnover as
the binding arm strengths continue to be increased, because
product release soon becomes rate-limiting.
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upon the catalytic core motif of the 8–17 deoxyribozyme
across several selection experiments. In one investigation,
Peracchi performed a comprehensive mutagenesis analysis
of the 8–17 deoxyribozyme and found that most mutants—
as well as the parent DNA enzyme itself—functioned with
10- to 20-fold higher kobs in the presence of Ca
2+ instead of
Mg
2+ (31). This was reminiscent of the Ca
2+-dependent Mg5
deoxyribozyme described above (28), and indeed the Mg5
deoxyribozyme was shown in this same study to incorporate
the 8–17 motif within its conserved core. When several non-
canonical interactions within the substrate binding arms of the
originally identiﬁed Mg5 deoxyribozyme were converted to
Watson–Crick base pairs, its catalytic activity was improved.
These changes also conferred upon Mg5 the ability to cleave
an all-RNA substrate, unlike the original Mg5 construct but
similar to 8–17 itself. In essence, Mg5 is the 8–17 deoxyri-
bozyme in masked form, although this relationship did not
become clear until 8–17 itself was formally identiﬁed (29)
and direct comparisons were made.
In asecondinvestigation,Lu and coworkers(32) usedselec-
tion strategy 2 of Figure 2 with the focused goal of ﬁnding
DNA enzymes that operate with transition metal ion cofactors
like Zn
2+ rather than alkaline earth metals like Mg
2+ or Ca
2+.
They successfully identiﬁed the Zn
2+-dependent 17E deoxyri-
bozyme, which—like the Mg5 deoxyribozyme—was found to
have the 8–17 catalytic core. An explanation for the varying
divalent metal ion dependencies of 8–17 and 17E was unclear
on the basis of their data. Although 8–17 itself was reported
to cleave only A#G RNA linkages (29), 17E cleaves A#G and
G#G equally well and about an order of magnitude faster than
it cleaves either U#Go rC #G.
Finally, in a comprehensive effort, Li and coworkers (36)
identiﬁed a family of 8–17-like deoxyribozymes that collec-
tively cleave almost any RNA dinucleotide junction. Their
selection strategy was initially designed to identify entirely
new RNA-cleaving deoxyribozymes using strategy 2 of
Figure 2. However, closely related variants of the 8–17 cat-
alyticmotif rapidlycametodominateallofthepools.This was
strong evidence that the 8–17 motif is the simplest solution for
the RNA cleavage problem and therefore highly favored in
DNA sequence space, just as the small hammerhead ribozyme
motif is favored in RNA sequence space (44).
Considering the interest in the roles of metal ions in nucleic
acid catalysis, Geyer and Sen (30) sought RNA-cleaving
deoxyribozymes that functioned independently of divalent
metal ions, M
2+. At the time of their study (1997), the ability
of some natural ribozymes to function without M
2+ was not yet
appreciated (45–47), so their effort was particularly thought-
provoking. Using strategy 2 of Figure 2, the self-cleaving
Na8 deoxyribozyme (Figure 3E) was identiﬁed after 12
selections rounds, cloning and six additional selection rounds.
The kobs for the Na8 deoxyribozyme was relatively modest
[0.007 min
 1 at 0.5 M NaCl (pH 7.0) and 25  C], but con-
sidering the estimated kuncat of only  3 · 10
 10 min
 1 in the
absence of M
2+, the rate enhancement kobs/kuncat of 2 · 10
7
was remarkable. The M
2+-independence of the Na8 deoxyri-
bozyme was convincingly demonstrated via a wide range of
control measures and analytical assays. Adding common
divalent metal ions such as Mg
2+,C a
2+ or Zn
2+ had no effect
upon activity. Furthermore, these M
2+ were ineffective in the
absence of Na
+, whereas monovalent ions other than Na
+ were
also effective cofactors. Several of the RNA-cleaving deoxyri-
bozymes from a separate effort by Faulhammer and Famulok
(28) as mentioned above are clearly related to Na8 by
sequence (30) and were shown to be metal-independent
DNA enzymes as well (43).
Another study from the Sen laboratory led to a DNA
enzyme with no apparent relationship to the 8–17 deoxyri-
bozyme (33). Using an N40 random region along with
strategy 1 of Figure 2 for 12 rounds of selection with a single
ribonucleotide in the substrate; cloning; and then seven
rounds of re-selection with a substrate incorporating several
ribonucleotides, the ‘bipartite DNAzyme’ was identiﬁed
(Figure 3F). This deoxyribozyme also interacts with its
RNA substrate using Watson–Crick binding arms, but it pre-
fers several unpaired nucleotides near the cleavage site. Under
multiple-turnover conditions with one particular substrate,
kcat ¼ 1 min
 1 and Km ¼ 200 nM [30 mM Mg
2+ (pH 7.4),
37 C]. The value of kcat/Km ¼ 5 · 10
6 M
 1 min
 1 is only
an order of magnitude lower than such values for natural
ribozymes such as the hammerhead and hairpin ribozymes.
An independent effort by Benner’s group led to the ‘614
deoxyribozyme’ that is Mg
2+-independent and also unrelated
to 8–17 (48).
Protein enzymes commonly use organic cofactors for catal-
ysis, so Roth and Breaker (40) sought to determine if RNA-
cleaving deoxyribozymes could depend not on divalent metal
ions but on a cofactor. Using strategy 2 of Figure 2 with an N40
region, and including EDTA to ensure the absence of free M
2+,
they identiﬁed several histidine-dependent deoxyribozymes
such as HD2 (Figure 3G). This process took 11 rounds of
selection followed by ﬁve rounds of re-selection, and the
resulting deoxyribozymes indeed require L-histidine as a
cofactor with Kd,app of  25 mM or greater. The pH depen-
dence of the reaction suggested a general base role for the
imidazole moiety of histidine during catalysis. The HD2
deoxyribozyme requires K
+ as well as imidazole, suggesting
the involvement of K
+-dependent DNA structures such as G
quartets.
TWO PRACTICAL CONSIDERATIONS FOR
THE SELECTION EXPERIMENTS
In all of the above studies, streptavidin (or a related protein)
and a biotinylated substrate were used as the physical basis
of the selection effort. In principle, gel-based methods could
instead be used to separate products on the basis of size
changes after RNA cleavage, analogous to what has been
done recently to identify deoxyribozymes that ligate RNA
(49). Nevertheless, the biotin-based methods appear to be
quite effective for identifying RNA-cleaving deoxyribozymes,
so other methods have not been necessary in practice.
It may not be immediately obvious why all of these selec-
tion procedures need to be iterated for multiple rounds to
identify catalytically active DNA sequences. If only particular
DNA sequences are catalytically competent to cleave RNA,
then why are they not identiﬁed in just a single round of
selection? The resolution of this issue lies in recognizing
that without exception, every DNA sequence has a nonzero
probability of having the attached RNA substrate become
cleaved during the allotted incubation time. For most DNA
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low; the DNA sequence is essentially ‘inactive’, and RNA
cleavage is not catalyzed by the attached DNA. However,
thereareavery largenumberofsuchcatalyticallyincompetent
DNA sequences in the initial pool. For a typical 200 pmol
initial pool ( 10
14 molecules), even if a large number (e.g.,
10
6) of the DNA sequences truly have substantial RNA cleav-
age activity, the vast majority of the pool (10
14   10
6   10
14
molecules) consists of ‘inactive’ DNA sequences. Simply by
chance, some of these nominally inactive DNA sequences will
have their RNA substrate cleaved during any particular
incubation period, and these inactive DNA sequences will
thus survive the selection round. The fraction of the pool
that contains truly catalytically competent DNA sequences
increases during each round of the selection procedure; i.e.,
the pool becomes enriched in catalytically active sequences.
However, multiple rounds are always needed in practice for
this enrichment to reach the point where the truly active
sequences constitute the dominant population. Experience
suggests that 4–10 rounds are typically needed for unambigu-
ous RNA cleavage activity to emerge from a random DNA
pool of length N40–N50. Of course, the exact number of rounds
to observe this emergence depends strongly on the details of
the selection design.
CHARACTERIZATION OF DEOXYRIBOZYMES
THAT CLEAVE RNA
The rate constants and catalytic efﬁciences included within
the above descriptions show that highly active RNA-cleaving
deoxyribozymes can be obtained by in vitro selection. In
terms of mechanism, diffusion-controlled catalytic efﬁciency
kcat/Km in the range of 10
9 M
 1 min
 1 with considerable
turnover (29,50) indicates that product release is not neces-
sarily rate-limiting. Although RNA-cleaving deoxyribozymes
are often well-behaved in terms of their kinetics, in at least one
case the 10–23 deoxyribozyme was observed to have biphasic
kinetics under single-turnover conditions (51), which suggests
the potential for mechanistic complexity. In general, the
mechanisms of RNA-cleaving deoxyribozymes are poorly
understood, and this is an area deserving of experimental
attention.
Formanyyears,itwasthoughtthatallribozymesareobliga-
tory metalloenzymes; i.e., that they require metals with val-
ence of two or more (52,53). However, a number of studies
have shown that some natural ribozymes can function without
divalent metal ions, although in such cases unusually high
concentrations of monovalent metal ions (e.g. 4 M Li
+) are
typically necessary (45–47). Similarly, some RNA-cleaving
deoxyribozymes such as Na8 do not require divalent metal ion
cofactors (30,43). Because the mechanisms of RNA-cleaving
deoxyribozymes are poorly understood, the implications of
divalent metal ion dependence (or independence) are unclear.
Curiously, binding of Ca
2+ to the Mg5 deoxyribozyme
involves at least two cooperative binding events in the intra-
molecular form of cleavage, whereas Mg
2+ binding does not
involve cooperativity (43). For a shortened version of the
10–23deoxyribozyme termed ML6,aspeciﬁcnucleotidedele-
tion switched the metal dependence of activity from favoring
Mg
2+ to favoring Ca
2+ (54). Overall, the roles of divalent
metal ions in DNA-catalyzed RNA cleavage appear to be
complicated.
The pH value is another experimental variable that can
be manipulated to provide information on deoxyribozyme
mechanisms. When they have been examined, most RNA-
cleaving deoxyribozymes are found to have a log-linear
dependence of rate on pH with slope near unity (32,50,55).
This is consistent with the requirement for a single deproto-
nation event during the reaction, similar to many ribo-
zymes in this regard (56–59). In contrast, the relative
pH-independence of the Na8 deoxyribozyme and the ‘bipartite
DNAzyme’ resembles that of the HDV ribozyme and sug-
gests acid-base catalysis rather than metal-ion-assisted
20-hydroxyl deprotonation (30,33). However, this type of
mechanism has not yet been demonstrated experimentally
for deoxyribozymes.
A common feature for all of the known RNA-cleaving
deoxyribozymes is the unpaired nature of the ribonucleotide
at the cleavage site. This unpaired nucleotide has plausibly
been speculated to provide the structural ﬂexibility necess-
ary to allow an in-line attack conformation of the attacking
20-hydroxyl nucleophile (39,43), although more direct experi-
mentalsupportforthis hypothesismustbeobtained. Several of
the RNA-cleaving deoxyribozymes (e.g. Na8 and ‘bipartite’)
prefer several unpaired nucleotides in the substrate near the
cleavage site (Figure 3). Because the 10–23 and 8–17 deoxyri-
bozymes need onlyonesuchunpaired nucleotide,thissuggests
different structural constraints upon the respective cleavage
mechanisms. It may not be a coincidence that the Na8 deoxyri-
bozyme and the ‘bipartite DNAzyme’ differ from 10–23
and 8–17 in both the nucleotide pairing near the cleavage
site and the pH dependence of their reactivity.
For proteins and nucleic acids alike, mutagenesis is a com-
mon approach to explore structure-function studies. Muta-
tional analysis of the enzyme region has been performed
for several RNA-cleaving deoxyribozymes, including 10–23
(60) and 8–17 (31,61). Effects of mutations to the 10–23
binding arms near the cleavage site have also been examined,
and rather subtle modiﬁcations were found to have a strong
inﬂuence upon activity (62). Additional biophysical analysis
of both folding and function has been performed for the 10–23
deoxyribozyme (63–65), the 8–17 deoxyribozyme (66–68)
and the original Pb
2+-dependent deoxyribozyme (69).
From the structural biology viewpoint (i.e. X-ray crystal-
lography and NMR spectroscopy), almost nothing is known
about deoxyribozymes that cleave RNA. Only one attempt to
crystallize a deoxyribozyme has been reported, using the
10–23 deoxyribozyme (70). However, the structure was not
of the catalytically active RNA:DNA complex (71), so mecha-
nistic information could not be inferred (the structure was
instead an interesting 2:2 RNA:DNA complex that resembles
a Holliday junction). Precise and mechanistically relevant
high-resolution structural information on any RNA-cleaving
deoxyribozyme will hopefully be obtained in the near future.
These efforts should be particularly informative with regard to
understanding the metal-ion dependence of RNA-cleaving
deoxyribozymes. Likely targets for study are the 8–17 variants
that prefer Mg
2+,C a
2+ or Zn
2+ as well as the 8–17-related Na8
deoxyribozyme that is M
2+-independent, along with other
deoxyribozymes that have curious metal dependencies such
as the ‘bipartite DNAzyme’ (33).
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CLEAVE RNA AS IN VITRO ‘RESTRICTION
ENZYMES’ FOR RNA
A signiﬁcant reason to study nucleic acid enzymes is their
conceptual relevance for understanding catalysis by naturally
occurring nucleic acids, and the efforts described above
indicate the progress in this regard. Artiﬁcial ribozymes and
deoxyribozymes may also be used for practical applications.
Deoxyribozymes are being applied with ever-increasing fre-
quency as straightforward laboratory reagents for cleavage of
speciﬁc RNA sequences—essentially, as ‘restriction enzymes’
for RNA (72). The 10–23 and 8–17 deoxyribozymes are cur-
rently the workhorses for this purpose. The potential use of
DNA for practical RNA cleavage was recognized in the initial
report that described 10–23 and 8–17 (29), and other instances
have since been reported. For example, RNA-cleaving deox-
yribozymes have been used to assist with large-scale RNA
preparation for structural biology experiments (73) and for
small-scale RNA cleavage reactions (74–76). Other applica-
tions along these lines are noted in a later section.
The original 10–23 and 8–17 deoxyribozymes have sub-
strate sequence requirements of R#Y and A#G, respectively,
where R denotes a purine (A or G) and Y is a pyrimidine (U or
C). Despite these limitations, 10–23 and 8–17 are quite useful
in practice. The family of 8–17-like deoxyribozymes obtained
byLiandcoworkers(36)expandsthe rangeofRNAsequences
that may be cleaved, thus providing a nearly universal means
of cleaving RNA using catalytic DNA. With the 8–17 variants
of Li and coworkers, most dinucleotide sequences N#N
may be cleaved in vitro with reasonable rate by choosing
the appropriate deoxyribozyme; only the combinations Y#C
and N#U are consistently poor substrates. In our laboratory,
we routinely use their 8–17 variants to cleave RNA sequences
for preparative purposes and also during in vitro selection
proceduresthatrequireRNAcleavage(77,78)(S.K.Silverman
and coworkers, unpublished data). In general, for in vitro
applications in which an RNA substrate needs to be cleaved
site-speciﬁcally, a deoxyribozyme such as 10–23 or 8–17 (or
one of their variants) should be considered for this
purpose.
For a deoxyribozyme to cleave its RNA target, binding
between the DNA and RNA must occur. A proposed rule
of thumb for designing the binding arms is that each arm
should have a binding free energy (DG ) of at least 10–
12 kcal/mol (72), as calculated on the basis of tabulated
RNA:DNA interaction energies (79). This is a good guideline
when the deoxyribozyme is used in excess of the cleavage
substrate; i.e., under single-turnover conditions. In contrast,
multiple-turnover conditions require that the deoxyribozyme
dissociate from the cleavage products, which suggests the use
of shorter binding arms. For in vitro applications, an excess of
deoxyribozyme can generally be used, and greater binding
afﬁnity ensures maximal RNA cleavage activity. Another
beneﬁt of longer Watson–Crick RNA:DNA binding arms is
that including additional DNA nucleotides can help to disrupt
secondary structure near the cleavage site in the RNA target,
when such secondary structure would otherwise inhibit bind-
ing of the DNA. Similarly, modifying the deoxyribozyme’s
binding arms by incorporating 20-methoxy or locked nucleic
acid (LNA) nucleotides can markedly improve cleavage
activity by increasing the binding afﬁnity for the RNA target
(80–82).
APPLICATION OF DEOXYRIBOZYMES THAT
CLEAVE RNA FOR IN VIVO TARGETING OF mRNA
A logical extension of DNA’s ability to cleave RNA in vitro is
the application of RNA-cleaving deoxyribozymes for cleaving
mRNAs in vivo. Several reviews have been published con-
cerning in vivo mRNA cleavage by deoxyribozymes (83–85),
some of which include extensive tables and literature refer-
ences (86–89). A growing number of individual reports have
described the in vivo application of RNA-cleaving deoxyri-
bozymestodegrade mRNA incellculture and sometimes even
in animal models; representative examples are cited here
(51,90–99). In general, RNA-cleaving deoxyribozymes should
have an important place alongside other in vivo therapies that
are based on nucleic acids, such as antisense oligonucleotides,
RNA-cleaving ribozymes and siRNA (86,100–103).
Several issues that are not of concern for in vitro applica-
tions become essential to consider for in vivo studies. The
deoxyribozyme must be delivered intracellularly to interact
with its mRNA target. Single-stranded DNA expression vec-
tors (104–109), electroporation (110), and modiﬁed delivery
agents (111) have been used for this purpose. Once inside a
cell, the DNA must remain stable on a relevant timescale. The
use of modiﬁed LNA nucleotides, which enhances substrate
binding afﬁnity as noted above, additionally helps to increase
speciﬁcity in targeting a desired mRNA among all of the
other RNAs within a cell (112). To suppress nuclease degrada-
tion, covalent conjugation (113) or terminal modiﬁcation
of deoxyribozymes have been used (114,115). Sometimes
more than one stabilization strategy has been applied
simultaneously (116).
Due to the complexities of living cells, extrapolating
efﬁcacy from in vitro assays is sometimes misleading, and
it can be frustrating to ﬁnd experimentally that a deoxyri-
bozyme known to work in vitro fails in vivo. One reason
for such failure may be the fact that deoxyribozymes such
as 10–23 and 8–17 were identiﬁed by in vitro selection
using different RNA substrates than are actually targeted
in a particular in vivo experiment. In such cases, it would
be sensible to identify deoxyribozymes that speciﬁcally
cleave precisely the desired target sequence; such an effort
is justiﬁed if cleavage of the particular target is a sufﬁciently
valuable objective. Towards this goal, as was done inde-
pendently with ribozymes (117), selections were performed
starting with a known 10–23 deoxyribozyme sequence and
selecting for particularly accessible cleavage sites in a certain
mRNA target, which were then successfully exploited in vivo
using the newly identiﬁed deoxyribozymes (118).
Cleavage of an mRNA molecule can be viewed not only
as a goal in itself, but also as the ﬁrst step in a multi-step
cleavage/ligation route for repairing aberrant mRNAs.
Indeed, ribozyme-mediated RNA repair processes have been
described (88,119–123). No deoxyribozymes have been
reported for this purpose, but the possibility is intriguing,
particularly because of the advantages of deoxyribozymes
over ribozymes for mRNA cleavage applications in terms
of cost and in vivo stability.
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A sensor can be created by the combination of a molecular
recognition event for a particular analyte with a signaling
event. Nucleic acid enzymes are particularly amenable to sen-
sor applications because their catalytic activities can be modu-
lated by speciﬁc analytes and because these activities can be
transduced into optically detected changes in several ways.
The Lu research group interfaced a Pb
2+-dependent RNA-
cleaving deoxyribozyme (32) with optical assays to create
sensitive Pb
2+ detectors. In these experiments, Pb
2+ is a
required cofactor for DNA-catalyzed RNA cleavage, so the
sensor is directly activated by the metal ion analyte. As shown
in Figure4A,cleavage ofanRNA substratethat islabeled with
both a ﬂuorophore and a quencher (e.g., TAMRA and Dabcyl)
results in a ﬂuorescence increase due to physical separation of
the quencher from the ﬂuorophore (124). Several improve-
ments to this system were made (125,126), including the
use of surface immobilization to improve the detection
limit to 10 nM Pb
2+ (127). Alternatively, gold nanoparticle
technology was exploited to design colorimetric Pb
2+ sensors,
using the principle that DNA-catalyzed RNA cleavage dis-
rupts gold nanoparticle aggegations, which changes the
color from blue to red (Figure 4B) (128). The same group
also designed an allosteric deoxyribozyme sensor for adenos-
ine by integrating an adenosine aptamer unit into the complex
between deoxyribozyme and RNA substrate (Figure 4C)
(129).The latter approach isrelated toa sensing assayreported
by Sen and coworkers (130–132), in which binding of the
oligonucleotide regulator was not dependent on binding of
a separate analyte; thus their system directly sensed the
oligonucleotide regulator itself. In general, such methods
have great promise for development of sensors based on
RNA-cleaving deoxyribozymes (22,133).
In separate efforts, Li and coworkers used in vitro selection
to identify ﬂuorescently signaling RNA-cleaving deoxyri-
bozymes (34), a collection of which has very broad speciﬁci-
ties for pH and metal ions (35). A key element of these studies
was that the ﬂuorophore and quencher combination were pre-
sent throughout each selection effort, rather than being grafted
onto a functional deoxyribozyme at the end of the selection
process. Therefore, the desired ﬂuorescence signaling activity
was directly identiﬁed. The Li group has recently character-
ized one of their signaling deoxyribozymes, pH6DZ1, ﬁnding
that it has a rather complex secondary structure when com-
pared with 10–23 and 8–17 (Figure 3H) (136). Although not
technically RNA-cleaving deoxyribozymes, an entire collec-
tion of ‘structure-switching signaling aptamers’ has also been
created by the same research group (137). In these designs, an
interaction between a nucleic acid and an analyte controls a
ﬂuorescence signal without any catalytic events. It is likely
that the principles from these experiments can be adapted for
regulation of deoxyribozyme catalysis. Indeed, the ﬁrst report
of a signaling deoxyribozyme also described creation of an
ATP-dependent allosteric sensor (34), and another effort along
these lines was recently reported (138).
Figure 4. RNA-cleavingdeoxyribozymesassensors.(A)TransducingDNA-catalyzedRNAcleavageintoafluorescencesignalbyseparationofafluorophoreanda
quencher. These are denoted F and Q, respectively (e.g., TAMRA and Dabcyl, although other combinations may be used). The fluorophore and quencher may be
placed in various places on the RNA substrate and deoxyribozyme, as long as RNA cleavage results in physical separation of F and Q (125). (B) Using gold
nanoparticles to induce a colorimetric signal upon RNA cleavage, which separates the nucleic acid strands that hold the nanoparticlestogether in an aggregate. The
RNAsubstratesarecoloredbrowntoavoidconfusionwiththeaggregated(blue)andseparated(red)goldnanoparticles.Thegoldnanparticlesareshownina‘head-
to-tail’ orientation (128,129,134), but subsequent efforts showed that a ‘tail-to-tail’ orientation is optimal (126,135). (C) An allosteric adenosine sensor that was
engineeredbycombininganaptamerwithadeoxyribozyme(129).ThedeoxyribozymebindswelltotheRNAsubstrateonlywhenadenosine(orange)isboundwith
the aptamer (pink), whereupon RNA cleavage is transduced to a color change via separation of the gold nanoparticles.
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bozymes as sensors in other ways. For example, Stojanovic
and coworkers (139) have created ﬂuorescent oligonucleotide
sensors and also detected protein–ligand interactions by teth-
ering biotin to a deoxyribozyme’s RNA substrate and modu-
lating RNA cleavage activity with streptavidin. In general,
combining the principles of deoxyribozyme catalysis with
various types of sensor assays appears to be a fruitful approach
for practical sensor development.
OTHER APPLICATIONS OF DEOXYRIBOZYMES
THAT CLEAVE RNA
RNA-cleaving deoxyribozymes have been applied for pur-
poses beyond those mentioned above. For example, such
deoxyribozymes have been used for detecting in vitro-
generated RNA modiﬁcations (140); for mapping sites of
in vitro RNA crosslinking (141); for mapping RNA branch
points (72,142,143); for probing higher-order RNA structure
(144); for quantifying nucleic acid production during PCR
ampliﬁcation (145); for analyzing nucleic acid sequence
mutations (146); for detecting speciﬁc microbial rRNAs
(147); for constructing logical computation circuits (148–
151); and for manipulating a DNA-based nanodevice (152).
A deoxyribozyme has been identiﬁed that cleaves unnatural
RNA linkages, which may be useful for certain biotechnology
applications (153). It is likely that additional interesting appli-
cations of RNA-cleaving deoxyribozymes will be developed
in the future.
RNA-CLEAVING DEOXYRIBOZYMES WITH
NONSTANDARD NUCLEOTIDES
RNA-cleaving deoxyribozymes with protein-like functional
groups have been selected from random-sequence DNA pools
that were prepared incorporating one or more unnatural
nucleotides (154–157). These unnatural nucleotides incorpor-
ate functionality such as imidazole and primary amino groups,
which are not found among the natural DNA nucleobases.
In some cases, use of such unnatural nucleotides requires a
technical advance in the selection methodology; e.g., more
tolerant DNA polymerases need to be identiﬁed (158). A com-
plete discussion of the catalytic possibilities that are enabled
by inclusion of unnatural nucleotides is beyond the scope of
this review. Nevertheless, it is clear that in principle, including
unnatural functional groups allows chemical possibilities
beyond those provided by standard DNA alone. Of course,
for practical applications it must be determined empirically
whether or not these new chemical possibilities justify the
synthetic effortnecessary tousenonstandard DNA nucleotides
in identifying new deoxyribozymes.
Nonstandard functional groups within nucleic acid enzymes
are not limited to those such as imidazole with special acid-
base properties. For example, at least two research groups
have described photochemically controlled deoxyribozymes
(159,160). This shows that unnatural nucleotides can be incor-
porated into DNA enzymes not for their direct catalytic con-
tributions but because they can modulate deoxyribozyme
function. Unnatural nucleotides can also be used to stabilize
the deoxyribozymes against nuclease degradation (161),
which is important for in vivo applications.
DEOXYRIBOZYMES THAT LIGATE RNA
RNA ligation by a deoxyribozyme is conceptually the ‘oppo-
site’ of RNA cleavage, because two RNA strands are joined
instead of cleaved. If the appropriate functional groups are
involved, then RNA ligation by a deoxyribozyme can be the
precise mechanistic reverse of cleavage as well. Our own
research group has focused strongly on identifying deoxyri-
bozymes that ligate RNA. In contrast to the uniform reaction
pathway of RNA cleavage (Figure 1), DNA-catalyzed RNA
ligation can occur in many ways, depending on the identities
ofthe substratesandthepathwaysbywhich theycanreact. Not
surprisingly, a wider variety of chemical reactions has been
observed for DNA-catalyzed RNA ligation when compared
with RNA cleavage [see (78,162,163) and references therein].
These RNA ligation experiments offer insight into the work-
ings of nature’s nucleic acid catalysts such as the ribosome (5)
and spliceosome (2,3), which also modulate bond-forming
reactions. Furthermore, some RNA-ligating deoxyribozymes
provide routes to important biomolecular targets such as lariat
RNAs that would be challenging or impossible to prepare by
other means (163). Therefore, RNA-ligating deoxyribozymes
offer practical utility as well as conceptual insights. Appli-
cations of deoxyribozymes that ligate RNA will certainly
increase in parallel with the applications of deoxyribozymes
that cleave RNA.
PERSPECTIVE
In only a little over a decade since their initial identiﬁcation,
artiﬁcial RNA-cleaving deoxyribozymes have grown from a
laboratory curiosity into widely appreciated research tools
both in vitro and in vivo. Fundamental investigations of
these deoxyribozymes should continue to offer substantial
insight into how catalysis can be achieved with nucleic acid
enzymes. For example, the identiﬁcation of histidine-
dependent deoxyribozymes (40) prompts a more general ques-
tion: what are the limits and implications of DNA and RNA
catalysisthatismediated byorganiccofactors?Equallyimpor-
tant are the opportunities enabled by combining DNA-
catalyzed RNA cleavage with practical applications. Such
applications currentlyrange from invitro preparative reactions
to in vivo mRNA degradation to realistic sensor systems. In all
of these areas, improvements can be expected. For example,
a future direction likely lies in using array technologies to
exploit RNA-cleaving deoxyribozyme sensors to the greatest
possible extent, much as ribozyme arrays are currently being
explored (164). One may anticipate that microﬂuidic and
nanoﬂuidic technologies (165) will also be integrated into
devices for applications that depend upon RNA-cleaving
deoxyribozymes.
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